BIOMETAL HEALTH
A PATENTED New Biometalâ„¢ With Controlled Resorption
We Redefine the $14B Spinal Implant Market

Challenges in Spinal Implant Surgery
Spinal health is a major global concern. 619 million people worldwide suffer from lower back pain, and 30 million Americans annually seek medical care for spine issues.
While spinal implants aim to alleviate this pain, procedures face significant hurdles. Alarmingly, up to 30% of spinal implants fail, with 90% of these failures occurring within the first six months post-surgery.
Poor Bone Fusion
Leads to delayed recovery and re-operations.
Infection Risks & Inflammation
Adverse inflammatory responses and risks of infection compromise patient health.
Compromised Stability
Issues like cage subsidence and screw loosening challenge long-term stability.
Suboptimal Integration
Existing titanium implants often fall short in promoting optimal biological integration, exacerbating these challenges.
BioMetal Health: A Revolutionary Spinal Solution
BioMetal Health introduces a patented new class of biometalâ„¢ technology, backed by $5.5M in non-dilutive R&D funding, designed to overcome critical challenges in spinal implant surgery. This advanced, biologically active spinal implant system integrates seamlessly with the body, setting new standards for patient recovery and long-term implant success.
Enhanced Bone Fusion
Our novel controlled resorbable biometal coating actively promotes osteointegration, significantly improving bone fusion rates and implant stability compared to traditional titanium devices.
Anti-Inflammatory Properties
Engineered to mitigate tissue irritation, our biometalâ„¢ technology reduces post-operative inflammation, leading to less pain and discomfort for patients and faster healing.
Anti-Infective Properties
The unique composition of our biometal provides inherent anti-infection capabilities, creating a hostile environment for bacterial colonization and enhancing patient safety.
This breakthrough revolutionizes titanium cage and screw spinal implants, combining superior biological integration with a proprietary Ti cage & screw design that "anchors" into vertebrae, leading to fewer failures and less pain for patients. This ushers in a new era of spinal care.
BioMetal Health: A Clear Competitive Edge
Our patented biometal technology offers a superior alternative to traditional spinal implants, addressing key limitations and significantly improving patient outcomes across critical performance metrics.
BioMetal Health: A Solution Like No Other
BioMetal Health's patented biometal technology offers a superior alternative to traditional spinal implants, addressing key limitations and significantly improving patient outcomes across critical performance metrics by delivering features competitors simply can't match.
Controlled Resorption
Unlike competitors, BioMetal Health implants are designed for controlled resorption, gradually integrating with the body as new bone forms. This eliminates the need for removal surgeries and promotes natural healing.
Low Stress Shielding
BioMetal Health minimizes stress shielding, a common issue with traditional implants. This ensures that natural bone is encouraged to bear load, promoting healthier, stronger bone remodeling and long-term stability.
Active Bone Growth
Our technology actively stimulates bone growth, directly contributing to stronger fusion and faster recovery. While some competitors offer limited or no bone growth support, BioMetal Health optimizes the healing process.
Anti-Inflammation Properties
BioMetal Health offers unmatched anti-inflammation capabilities, a critical feature completely absent in all competitor implants. This significantly reduces the risk of post-operative inflammation, enhancing patient recovery.
Significant Market Opportunity in Spinal Implants
The global spinal implant market is experiencing robust growth, driven by an aging population, increasing incidence of spinal conditions, and a rising demand for advanced surgical solutions. Current implant technologies often fall short, creating a critical need for innovation.
$14B
Global Market Size (Spinal Implants)
A substantial and growing segment within the medical device industry.
6.8%
Projected CAGR (2024-2030)
Steady growth fueling demand for more effective, patient-friendly solutions.
4.5M+
Implants Annually
High procedure volume underscores the widespread need for superior performance
70%+
Implant Gross Margins
Strong unit economics offer substantial profitability for innovative solutions.
This escalating demand, coupled with the limitations of existing titanium implants, highlights a significant opportunity for BioMetal Health's patented biometal technology to redefine patient care and capture market share. BioMetal Health projects $154M in revenue by 2032, driven by strong unit economics and high interest from spine surgeons. Additionally, the broader bone fracture fixation global market is projected to reach $25B by 2032, further expanding the potential for BioMetal Health's innovative solutions.
Leading Spine Surgeons Endorse BioMetal Health
"Spine surgeons are seeking devices that actively promote bone healing. BioMetal Health's concept could be a breakthrough!"
Peter Passias, M.D.
Professor, Department of Orthopaedic Surgery, Duke University
"Implant failures remain a major issue. We need a true game changer, and BioMetal Health has that potential."
Yoshifumi Kudo, M.D., Ph.D.
Chair, Department of Orthopaedics, Showa Medical University, Japan
"The key to success is achieving solid fusion as quickly as possible. Current devices are inadequate for this, and BioMetal Health may help address that gap."
Koichiro Ono, M.D., Ph.D.
Associate Professor, Department of Orthopaedics, Nippon Medical School, Japan
Proven Team: Bio-Materials, Spine, Commercialization
Jerry Yen, MS, MBA
Chief Executive Officer
3 startups, $5M+ raised in AI, 3D Print, Commercial
Jack Zhou, PhD
Chief Science Officer
20+ patents, 200+ papers in Bio-materials, 3D Print
Adam Colton, MBA
Chief Operating Officer
5 startups, CEO/CFO/COO experience in Healthcare, Sports, Tech
Koji Ishikawa, MD, PhD
Chief Medical Officer
Orthopaedic Spine Surgeon and Scientist, 50+ Publications, Multiple Awards, Global Invited Speaker
Tabari Baker, PhD
Chief Commercial Officer
Medical/Regulatory Affairs, FDA concept to market
Three Phases to Product Launch
1
Q4 2025 - Q3 2026
Phase 1: Patent Fortress Expansion & FDA Preparation
  • FDA 510(k) Class II predicate
  • Product design/planning
  • Patent portfolio strategy
  • Contract manufacturing/supply chain
2
Q4 2026 - Q4 2027
Phase 2: FDA Q-Submission & Quality Management
  • FDA 510(k) Q-sub planning
  • Product lock/manufacturing/QMS
  • Performance/Safety Data
  • Patent portfolio acquisition
3
Q1 2028 - Q4 2028
Phase 3: Clinical & FDA Submissions
  • FDA 510(k) Submission/Review/Clearance
  • Manufacturing/supply chain/asset mgmt
  • Patent portfolio business planning
  • Commercialization - KOL, distribution
Partner with BioMetal Health: Shape the Future of Spinal Care
BioMetal Health invites you to be part of the revolution in spinal implant technology. We are actively seeking strategic partners to accelerate our mission.
Strategic Partnerships
Collaborate on clinical trials, distribution, or R&D to integrate our patented biometal technology into new applications and markets.
For Accredited Investors Only
Invest in a high-growth medical device company poised to disrupt the spinal implant market with superior patient outcomes and a strong patent portfolio.
Connect with Us
Explore how BioMetal Health can benefit your organization. Reach out for a detailed presentation or to discuss bespoke collaboration models.
Get in Touch with BioMetal Health
Send Us a Message
For inquiries, partnerships, or accredited investment opportunities, please reach out directly.
Email Us Directly
Connect on LinkedIn
Follow our journey and stay updated on the latest breakthroughs and company news.